Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Sacubitril/Valsartan in African American Patients With Heart Failure With Reduced Ejection Fraction

NCT05168787 is registered in ClinicalTrials.gov with Methodist Health System as lead sponsor.

NCT NCT05168787
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05168787 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Sacubitril/Valsartan in African American Patients With Heart Failure With Reduced Ejection Fraction
Lead sponsor
Methodist Health System
Phase
Observational
Overall status
Completed
Start date
August 13, 2020
Completion date
July 8, 2025
Enrollment
6,558 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure